• “Fake news” can misrepresent aspects of medical research. • The open access publication model has been compromised by “predatory journals. • While pharmaceutical companies sponsor much credible medical education, mishandling of this opportunity can be a potent portal for fake news. • Two websites publish a facsimile of the earnings of opinion leaders who participate in promotional endeavors. As presented, this information is sometimes misleading. • Interpretation of reporting rules is not consistent among pharmaceutical companies.
Dermatology Times – Dermatology